Search Results for "Pregnancy"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Pregnancy. Results 11 to 20 of 355 total matches.
Comparison Table: Some Drugs for Gout (online only)
The Medical Letter on Drugs and Therapeutics • Oct 30, 2023 (Issue 1688)
Cost1 Class Adverse Effects/Pregnancy and Lactation Class Drug Interactions Class Comments
Anti ...
View the Comparison Table: Some Drugs for Gout
Med Lett Drugs Ther. 2023 Oct 30;65(1688):e176-9 doi:10.58347/tml.2023.1688c | Show Introduction Hide Introduction
Comparison Table: Some Drugs for Plaque Psoriasis (online only)
The Medical Letter on Drugs and Therapeutics • Sep 30, 2024 (Issue 1712)
Dosage3 Adverse Effects and Drug Interactions Pregnancy and Lactation4 Class Comments
Topical Vitamin D ...
View the Comparison Table: Some Drugs for Plaque Psoriasis
Med Lett Drugs Ther. 2024 Sep 30;66(1712):e160-6 doi:10.58347/tml.2024.1712b | Show Introduction Hide Introduction
Drugs for Multiple Sclerosis
The Medical Letter on Drugs and Therapeutics • Mar 22, 2021 (Issue 1620)
Pregnancy and Lactation – Interferon beta is generally
considered safe for use in pregnant ...
Most patients with multiple sclerosis (MS) present
with the relapsing-remitting form of the disease.
Pharmacologic treatment usually includes a
disease-modifying drug, corticosteroids for acute
exacerbations, and other drugs for managing
symptoms such as fatigue, depression, and pain.
Early use of disease-modifying therapy has improved
clinical outcomes.
Comparison Table: Some Drugs for Migraine Prevention in Adults (online only)
The Medical Letter on Drugs and Therapeutics • Jun 12, 2023 (Issue 1678)
Precautions Pregnancy Comments Cost1
Beta Blockers
Metoprolol2 – generic
Lopressor (Validus)
extended ...
View the Comparison Table: Some Drugs for Migraine Prevention in Adults
Med Lett Drugs Ther. 2023 Jun 12;65(1678):e100-2 doi:10.58347/tml.2023.1678c | Show Introduction Hide Introduction
Expanded Table: Some Vaccines for Adults (online only)
The Medical Letter on Drugs and Therapeutics • Oct 17, 2022 (Issue 1661)
and
induration, are common
Arthus-type reactions can
occur rarely
Inactivated vaccine
Pregnancy: Tdap during ...
Comparison Table: Some Drugs for HFrEF (online only)
The Medical Letter on Drugs and Therapeutics • Mar 08, 2021 (Issue 1619)
valsartan serum concentrations4
Contraindicated for use during pregnancy because valsartan can increase ...
View the Comparison Table: Some Drugs for HFrEF
Expanded Table: Some Conventional DMARDs for Rheumatoid Arthritis (online only)
The Medical Letter on Drugs and Therapeutics • Nov 15, 2021 (Issue 1637)
Pregnancy and Lactation Some Adverse Effects Comments Cost2
Methotrexate, oral –
generic
Trexall (Duramed ...
View Expanded Table: Some Conventional DMARDs for Rheumatoid Arthritis
Comparison Table: Some FDA-Approved Drugs for Weight Management (online only)
The Medical Letter on Drugs and Therapeutics • May 30, 2022 (Issue 1651)
heart rate
and blood pressure and cause nervousness
▶ Contraindications
■ Pregnancy/breastfeeding ...
View the Comparison Table: Some FDA-Approved Drugs for Weight Management
Phexxi - A Nonhormonal Contraceptive Gel
The Medical Letter on Drugs and Therapeutics • Aug 24, 2020 (Issue 1605)
vaginal gel containing lactic acid, citric acid,
and potassium bitartrate, for prevention of pregnancy ...
The FDA has approved Phexxi (Evofem), a
nonhormonal prescription-only vaginal gel containing
lactic acid, citric acid, and potassium bitartrate, for
prevention of pregnancy. The gel is intended for on-demand
contraception; it is not effective when used
after intercourse. It was previously approved for
use as a vaginal lubricant (Amphora), but was never
marketed.
Drugs for Sexually Transmitted Infections
The Medical Letter on Drugs and Therapeutics • Jun 27, 2022 (Issue 1653)
are common and can
lead to poor adherence and treatment failure.
Pregnancy – A single dose of oral ...
This article includes recommendations for management
of most sexually transmitted infections (STIs)
other than HIV and viral hepatitis. Some of the
indications and dosages recommended here have
not been approved by the FDA (see Table 1).